The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
New and unusual scaffolds in medicinal chemistry
Abstract
Contemporary medicinal chemistry faces diverse challenges from several directions, including the need for both potency and specificity of any therapeutic agent; the increasingly demanding requirements of low toxicity shown across all patients treated; and the need for novelty in intellectual property, given the extensive use of benzenoid and heteroaromatic ring systems in numerous patents. Increasingly, such challenges are being met by a shift to new and/or unusual ring systems (scaffolds) that lie outside the field of (hetero)aromatic systems. This critical review surveys a necessarily limited selection of currently atypical scaffolds, chiefly drawn from the literature of the last three years, that have found application in medicinal chemistry, some being present in agents with therapeutic potential while others are found in agents already in clinical use (163 references).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
The exploration of macrocycles for drug discovery — an underexploited structural class
Driggers, E. M., Hale, S. P., Lee, J., & Terrett, N. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2590 · Cited by 1,370
Oxetanes in Drug Discovery: Structural and Synthetic Insights
Wuitschik, G., Carreira, E. M., Wagner, B., Fischer, H., Parrilla, I., Schuler, F., Rogers-Evans, M., & Müller, K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9018788 · Cited by 418
Jung, M. E., Ouk, S., Yoo, D., Sawyers, C. L., Chen, C., Tran, C., & Wongvipat, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901488g · Cited by 266
Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
Xia, Z., Knaak, C., Ma, J., Beharry, Z. M., McInnes, C., Wang, W., Kraft, A. S., & Smith, C. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800937p · Cited by 194
2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1Receptor Agonists
Bolli, M. H., Abele, S., Binkert, C., Bravo, R., Buchmann, S., Bur, D., Gatfield, J., Hess, P., Kohl, C., Mangold, C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100181s · Cited by 179
Kyprianou, N., & Benning, C. M. (2000) · PubMed · Cited by 150
Malamas, M. S., Erdei, J., Gunawan, I., Turner, J., Hu, Y., Wagner, E. J., Fan, K. Y., Chopra, R., Olland, A. M., Bard, J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901414e · Cited by 132
Benning, C. M., & Kyprianou, N. (2002) · PubMed · Cited by 127
Zhu, Z., Sun, Z. J., Ye, Y., Voigt, J. H., Strickland, C., Smith, E. M., Cumming, J. N., Wang, L., Wong, J. K. Y., Wang, Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901408p · Cited by 121
Aminoimidazoles as Potent and Selective Human β-Secretase (BACE1) Inhibitors
Malamas, M. S., Erdei, J., Gunawan, I., Barnes, K. D., Johnson, M., Hui, Y., Turner, J., Hu, Y., Wagner, E. J., Fan, K. Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9006752 · Cited by 114
The Structure−Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277)
Dong, Y., Wittlin, S., Sriraghavan, K., Chollet, J., Charman, S. A., Charman, W. N., Scheurer, C., Urwyler, H., Tomas, J. S., Snyder, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901473s · Cited by 110
Mohan, S., McAtamney, S., Haselhorst, T., von Itzstein, M., & Pinto, B. M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100822f · Cited by 93
Lavieri, R. R., Scott, S. A., Selvy, P. E., Kim, K., Jadhav, S. B., Morrison, R. D., Daniels, J. S., Brown, H. A., & Lindsley, C. W. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100814g · Cited by 90
Moffat, D. F. C., Patel, S. R., Day, F. A., Belfield, A. J., Donald, A., Rowlands, M., Wibawa, J. I. D., Brotherton, D. H., Stimson, L., Clark, V., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101177s · Cited by 83
Gomez-Monterrey, I. M., Bertamino, A., Porta, A., Carotenuto, A., Musella, S., Aquino, C., Granata, I., Sala, M., Brancaccio, D., Picone, D., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100838z · Cited by 83
Véniant, M. M., Hale, C., Hungate, R. W., Gahm, K. H., Emery, M. G., Jona, J. A., Joseph, S., Adams, J., Hague, A. B., Moniz, G. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100242d · Cited by 81
Marson, C. M. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009788679976 · Cited by 81
Self-citationPseurotin A and its analogues as inhibitors of immunoglobuline E production
Ishikawa, M., Ninomiya, T., Akabane, H., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.029 · Cited by 79
Preparation of Aryloxetanes and Arylazetidines by Use of an Alkyl−Aryl Suzuki Coupling
Duncton, M. A. J., Estiarte, M. A., Tan, D. Q., Kaub, C. J., O’Mahony, D. J. R., Johnson, R. J. K., Cox, M. O., Edwards, W. T., Wan, M., Kincaid, J., et al. (2008) · Organic Letters · doi:10.1021/ol8011327 · Cited by 78
O’Donnell, C. J., Rogers, B. N., Bronk, B. S., Bryce, D. K., Coe, J. W., Cook, K. K., Duplantier, A. J., Evrard, E., Hajós, M., Hoffmann, W. E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9015075 · Cited by 76
Brown, A. D., Brown, T. B., Calabrese, A. A., Ellis, D. J., Puhalo, N., Ralph, M. J., & Watson, L. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.097 · Cited by 73
Carolan, C. G., Dillon, G. P., Khan, D., Ryder, S. A., Gaynor, J. M., Reidy, S., Marquez, J. F., Jones, M., Holland, V., & Gilmer, J. F. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9014845 · Cited by 70
Xu, M., Andrews, K. T., Birrell, G. W., Tran, T. L., Camp, D., Davis, R. A., & Quinn, R. J. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.081 · Cited by 69
Sato, K., Seio, K., & Sekine, M. (2002) · Journal of the American Chemical Society · doi:10.1021/ja027131f · Cited by 62
Smith, T., Young, B. L., Denton, H., Hughes, D. L., & Wagner, G. K. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.083 · Cited by 59
Rupp, M., Schroeter, T. S., Steri, R., Zettl, H., Proschak, E., Hansen, K., Rau, O., Schwarz, O., Müller‐Kuhrt, L., Schubert‐Zsilavecz, M., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900469 · Cited by 54
Pasquini, S., Ligresti, A., Mugnaini, C., Semeraro, T., Cicione, L., Rosa, M. D., Guida, F., Luongo, L., Chiaro, M. D., Cascio, M. G., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100123x · Cited by 52
Design and Preparation of Potent, Nonpeptidic, Bioavailable Renin Inhibitors
Bezençon, O., Bur, D., Weller, T., Richard‐Bildstein, S., Remeň, L., Sifferlen, T., Corminboeuf, O., Grisostomi, C., Boss, C., Prade, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900022f · Cited by 51
Hayashi, S., Hirao, A., Imai, A., Nakamura, H., Murata, Y., Ohashi, K., & Nakata, E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm7012979 · Cited by 50
Novel KCNQ2/Q3 Agonists as Potential Therapeutics for Epilepsy and Neuropathic Pain
Fritch, P. C., McNaughton-Smith, G. A., Amato, G. S., Burns, J. F., Eargle, C. W., Roeloffs, R., Harrison, W., Jones, L. S., & Wickenden, A. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901497b · Cited by 49
Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B RNA polymerase
Habermann, J., Capitò, E., Ferreira, M. D. R. R., Koch, U., & Narjes, F. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.039 · Cited by 47
Kinzel, O. D., Llauger, L., Pescatore, G., Rowley, M., Schultz‐Fademrecht, C., Monteagudo, E. S., Fonsi, M., Paz, O. G., Fiore, F., Steinkühler, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9004303 · Cited by 46
Schlienger, N., Lund, B. W., Pawlas, J., Badalassi, F., Bertozzi, F., Lewinsky, R., Fejzic, A., Thygesen, M. B., Tabatabaei, A., Bradley, S. R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901149c · Cited by 46
Nonpeptidic and Potent Small-Molecule Inhibitors of cIAP-1/2 and XIAP Proteins
Sun, H., Lü, J., Liu, L., Han, Y., Qiu, S., Yang, C., Deschamps, J. R., & Wang, S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100487z · Cited by 44
Watterson, S. H., Xiao, Z., Dodd, D. S., Tortolani, D. R., Vaccaro, W. D., Potin, D., Launay, M., Stetsko, D. K., Skala, S., Davis, P. M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100348u · Cited by 43
Richard, D. J., Verheijen, J. C., Curran, K. J., Kaplan, J. A., Toral‐Barza, L., Hollander, I. J., Lucas, J., Yu, K., & Zask, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.096 · Cited by 43
Arumugam, N., Raghunathan, R., Shanmugaiah, V., & Mathivanan, N. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.084 · Cited by 42
Cohen, F., Alicke, B., Elliott, L. O., Flygare, J. A., Goncharov, T., Keteltas, S. F., Franklin, M. C., Frankovitz, S. M., Stéphan, J.-P., Tsui, V., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801450c · Cited by 41
Li, Q., Wu, J., Zheng, H., Liu, K., Guo, T. L., Liu, Y., Eblen, S. T., Grant, S., & Zhang, S. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.030 · Cited by 40
Sun, W. D., Nikolovska‐Coleska, Z., Qin, D., Sun, H., Yang, C., Bai, L., Qiu, S., Wang, Y., Ma, D., & Wang, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801101z · Cited by 39
Mao, W.-W., Wang, T., Zeng, H., Wang, Z., Chen, J., & Shen, J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.098 · Cited by 38
Pyridinyl aminohydantoins as small molecule BACE1 inhibitors
Zhou, P., Li, Y., Fan, Y., Wang, Z., Chopra, R., Olland, A. M., Hu, Y., Magolda, R. L., Pangalos, M. N., Reinhart, P. H., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.136 · Cited by 36
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)
Boatman, P. D., Schrader, T. O., Kasem, M., Johnson, B. R. G., Skinner, P. J., Jung, J., Xu, J., Cherrier, M. C., Webb, P. J., Semple, G., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.062 · Cited by 34
Crombie, A. L., Antrilli, T. M., Campbell, B. A., Crandall, D. L., Failli, A. A., He, Y., Kern, J. C., Moore, W., Nogle, L. M., & Trybulski, E. J. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.068 · Cited by 30
Sato, N., Ando, M., Ishikawa, S., Jitsuoka, M., Nagai, K., Takahashi, H., Sakuraba, A., Tsuge, H., Kitazawa, H., Iwaasa, H., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900110t · Cited by 28
Biaryl substituted hydantoin compounds as TACE inhibitors
Yu, W., Tong, L., Kim, S. H., Wong, M., Chen, L., Yang, D., Shankar, B. B., Lavey, B. J., Zhou, G., Kosinski, A., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.134 · Cited by 28
Lepifre, F., Christmann‐Franck, S., Roche, D., Leriche, C., Carniato, D., Charon, C., Hallakou‐Bozec, S., Doaré, L., Schmidlin, F., Lecomte, M., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.123 · Cited by 28
Nowak, P., Cole, D. C., AULABAUGH, A. E., Bard, J., Chopra, R., Cowling, R. A., Fan, K. Y., Hu, B., Jacobsen, S. J., Jani, M., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.052 · Cited by 27
Singh, C., Hassam, M., Naikade, N. K., Verma, V. P., Singh, A. S., & Puri, S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100678p · Cited by 26
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors
McMinn, D. L., Rew, Y., Sudom, A. M., Caille, S., DeGraffenreid, M. R., He, X., Hungate, R. W., Jiang, B., Jaén, J. C., Julian, L. D., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.026 · Cited by 24
Rigid Analogues of the α2-Adrenergic Blocker Atipamezole: Small Changes, Big Consequences
Vacher, B., Funes, P., Chopin, P., Cussac, D., Heusler, P., Tourette, A., & Marien, M. R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1006269 · Cited by 22
Bunnelle, W. H., Tietje, K. R., Frost, J. M., Peters, D., Ji, J., Li, T., Scanio, M. J. C., Shi, L., Anderson, D. J., Dyhring, T., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900249k · Cited by 22
TAKAHASHI, J. C., Hijikuro, I., Kihara, T., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.035 · Cited by 21
Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents
Ahmad, S., Ngu, K., Miller, K. J., Wu, G. Y., Hung, C.-P., Malmstrom, S. E., Zhang, G., O’Tanyi, E., Keim, W. J., Cullen, M. J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.014 · Cited by 20
Yu, Y., Dwyer, M. P., Chao, J., Aki, C., Chao, J., Biju, P., Rindgen, D., Bond, R. W., Mayer-Ezel, R., Jakway, J. P., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.024 · Cited by 19
Kwon, S. W., Kang, S. K., Lee, J. H., Bok, J. H., Kim, C. H., Rhee, S. D., Jung, W. H., Kim, H. Y., Bae, M. A., Song, J. S., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.123 · Cited by 18
Sato, N., Jitsuoka, M., Ishikawa, S., Nagai, K., Tsuge, H., Ando, M., Okamoto, O., Iwaasa, H., Gomori, A., Ishihara, A., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.101 · Cited by 17
Bicyclic cyanothiazolidines as novel dipeptidyl peptidase 4 inhibitors
Betancort, J. M., Winn, D. T., Liu, R., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.048 · Cited by 17
Effect of the virostatic norakin® (triperiden) on influenza virus activities
Ott, S., & Wunderli‐Allenspach, H. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90050-7 · Cited by 16
Tang, G., Qiu, Z., Lin, X., Li, W., Zhu, L., Li, S., Li, H., Wang, L., Chen, L., Wu, J. Z., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.141 · Cited by 16
Pettersson, M., Campbell, B. M., Dounay, A. B., Gray, D. L., Xie, L., O’Donnell, C. J., Stratman, N. C., Zoski, K. T., Drummond, E. M., Bora, G., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.066 · Cited by 15
Cho, T. P., Long, Y. F., Gang, L. Z., Wang, Y., Jun, L. H., Yuan, S. G., Hong, F. J., Wang, L., Liang, G. D., Lei, Z., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.120 · Cited by 13
Design, syntheses, and SAR of 2,8-diazaspiro[4.5]decanones as T-type calcium channel antagonists
Fritch, P. C., & Krajewski, J. L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.098 · Cited by 12
A novel series of [3.2.1] azabicyclic biaryl ethers as α3β4 and α6/4β4 nicotinic receptor agonists
Lowe, J. A., III, DeNinno, S. L., Coe, J. W., Zhang, L., Mente, S., Hurst, R. S., Mather, R. J., Ward, K. M., Shrikhande, A., Rollema, H., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.142 · Cited by 11
An octahydro-cyclopenta[c]pyrrole series of inhibitors of the type 1 glycine transporter
Lowe, J. A., III, DeNinno, S. L., Drozda, S. E., Schmidt, C. J., Ward, K. M., Tingley, F. D., Sanner, M. A., Tunucci, D., & Valentine, J. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.071 · Cited by 11
Li, T., Bunnelle, W. H., Ryther, K. B., Anderson, D. J., Malysz, J., Helfrich, R. J., Grønlien, J. H., Håkerud, M., Peters, D., Schrimpf, M. R., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.105 · Cited by 11
Cho, T. P., Gang, L. Z., Long, Y. F., Yang, W., Qian, W., Lei, Z., Jing, L., Ying, F., Ke, Y. P., Leng, Y., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.138 · Cited by 10
Azabicyclic sulfonamides as potent 11β-HSD1 inhibitors
Shah, U., Boyle, C. D., Chackalamannil, S., Baker, H. E., Kowalski, T. J., Lee, J., Terracina, G., & Zhang, L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.082 · Cited by 9
Zuev, D., Vrudhula, V. M., Michne, J. A., Dasgupta, B., Pin, S. S., Huang, X. S., Wu, D., Gao, Q., Zhang, J., Taber, M. T., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.094 · Cited by 9
Mortell, K. H., Schrimpf, M. R., Bunnelle, W. H., Anderson, D. J., Grønlien, J. H., Thorin‐Hagene, K., & Gopalakrishnan, M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.023 · Cited by 5
Cited by
The use of spirocyclic scaffolds in drug discovery
Zheng, Y., Tice, C. M., & Singh, S. B. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.081 · Cited by 1,036
Westerhaus, F. A., Jagadeesh, R. V., Wienhöfer, G., Pohl, M.-M., Radnik, J., Surkus, A.-E., Rabeah, J., Junge, K., Junge, H., Nielsen, M., et al. (2013) · Nature Chemistry · doi:10.1038/nchem.1645 · Cited by 732
Visible-light induced dearomatization reactions
Cheng, Y.-Z., Feng, Z., Zhang, X., & You, S.-L. (2022) · Chemical Society Reviews · doi:10.1039/c9cs00311h · Cited by 366
All-carbon quaternary centers in natural products and medicinal chemistry: recent advances
Ling, T., & Rivas, F. (2016) · Tetrahedron · doi:10.1016/j.tet.2016.09.002 · Cited by 312
D'Acunto, C. W., Kaplánek, R., Gbelcová, H., Kejík, Z., Bříza, T., Vasina, L., Havlík, M., Ruml, T., & Král, V. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.084 · Cited by 26
Metadata
- Authors
- Marson, C. M.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2011
- Volume
- 40
- Issue
- 11
- Pages
- 5514
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2089214220
- Cited by
- 413
- References
- 72
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.